-
[Editor's note: With this issue, we begin a quarterly column on coding in the ED by Caral Edelberg, president of Edelberg Compliance Associates. If there are coding issues you would like to see addressed in this column, contact: Caral Edelberg, CPC, CCS-P, CHC, Edelberg Compliance Associates, Baton Rouge, LA. Phone: (225) 454-0154. EFAX Number: (225) 612-6904.]
-
What should be done if the ED patient disagrees with what is documented or perceives that the record is incomplete?
-
If you want to give patients gift cards as a way to say "sorry" for that long wait in the ED or anything else that left them unhappy feel free. The government says you're not violating any prohibitions on improper remuneration.
-
One way to get your staff flu vaccination rates higher is to make it as easy as possible for them to obtain a vaccination, says David Ross, DO, an emergency physician at Penrose Hospital in Colorado Springs, CO. Ross says his hospital's staff vaccination rate has risen from 63% to 73% in the past year.
-
The Joint Commission has released a statement that effective Jan. 1, 2009, there will be new simplified scoring and decision processes for all accreditation and certification programs that "better reflect an organization's performance regarding compliance with Joint Commission standards and elements of performance [EPs]."
-
The Joint Commission and the Urgent Care Association of America (UCAOA) have formed a partnership to provide quality oversight for urgent care clinics.
-
-
Moll and colleagues from Amsterdam performed a subgroup analysis within their randomized clinical trial of women with polycystic ovary syndrome comparing metformin plus clomiphene treatment with clomiphene alone.
-
Glinert and colleagues from Israel report the use of photodynamic therapy to successfully ablate single feto-placental implantations in rats.
-
July of this year represented the 5-year anniversary of the publication of Gynecologic Oncology Group (GOG) protocol 178, a pivotal trial demonstrating the significant impact of 9 additional months of paclitaxel chemotherapy to women who had achieved a complete clinical response to primary therapy.
